Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)

Taiwan · Delayed Price · Currency is TWD

13.60

-0.60 (-4.23%)

At close: Sep 11, 2026

Market Cap	1.09B -39.9%
Revenue (ttm)	718.16M +20.1%
Net Income	-25.70M
EPS	-0.35
Shares Out	80.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	73,316
Open	13.85
Previous Close	14.20
Day's Range	13.35 - 13.85
52-Week Range	13.40 - 36.85
Beta	-0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 16, 2026

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; clinical testing services, such as reproductive health and cancer testing services; and contract development and manufacturing services. The company was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2001

Country Taiwan

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 4195

Full Company Profile

Financial Performance

In 2025, Genomics BioSci & Tech.'s revenue was 708.38 million, an increase of 36.86% compared to the previous year's 517.58 million. Losses were -39.43 million, -82.33% less than in 2024.

Financial Statements